3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide

3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Struktur
1675248-19-7
CAS-Nr.
1675248-19-7
Englisch Name:
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
Synonyma:
Tofacitinib-24;Tofacitinib Imp.Q;Tofatinib Impurity Q;Tofacitinib Impurity JJ;Tofacitinib Related Compound 7;Tofacitinib Citrate Impurity 05;Azilsartan medoxomil impurity333;1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-;1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-;3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
CBNumber:
CB42666835
Summenformel:
C16H22N6O2
Molgewicht:
330.39
MOL-Datei:
1675248-19-7.mol

3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Eigenschaften

Löslichkeit
DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
Farbe
Off-White to Pale Orange

Sicherheit

3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.

3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 77)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3149 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131981 58
Shanghai Payne Pharmaceutical Technology Co.Ltd
021-58123769 18678586262
info@paynepharm.com China 1354 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341 13101896326
shiqingran@wzxchem.com China 1967 58
Adamas Reagent, Ltd. 400-6009262 16621234537
zhangsn@titansci.com China 14113 59

1675248-19-7()Verwandte Suche:


  • 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
  • Tofacitinib Imp.Q :3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
  • Tofacitinib-24
  • Tofacitinib Citrate Impurity 05
  • Tofacitinib Related Compound 7
  • Tofacitinib Impurity JJ
  • Tofacitinib impurity 18/3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
  • Tofacitinib Imp.Q
  • 1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
  • Azilsartan medoxomil impurity333
  • Tofatinib Impurity Q
  • 1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
  • 1675248-19-7
  • 2227195-31-5
Copyright 2019 © ChemicalBook. All rights reserved